The ability to block PD-L1 and sequester TGF-β was required for the anti-tumor efficacy of bintrafusp alfa, as TGF-β sequestration alone by the bintrafusp alfa mutant did not improve anti-tumor responses. This evidence concerns the gene TGFB1 and neoplasm.